EUROSPITAL COELIAC DISEASE PRODUCT LINE

The most complete and reliable panel of products for the in vitro diagnosis of coeliac disease.

From early identifi cation through the most comprehensive defi nition of the coeliac patient and prevention of the disease.

Why Eurospital

Eurospital is a family company with more than 30 years of experience in the identifi cation of both symptomatic and asymptomatic
coeliac disease patients, owner of the european patent (EP 0912898) for the use of the tissue transglutaminase (tTG) as a marker
for the in vitro determination of the coeliac disease.